Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$135.05 - $182.59 $580,444 - $784,771
-4,298 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$145.58 - $192.14 $625,702 - $825,817
4,298 New
4,298 $626,000
Q1 2021

May 17, 2021

SELL
$140.25 - $196.86 $1.03 Million - $1.45 Million
-7,374 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$126.47 - $163.7 $499,682 - $646,778
3,951 Added 115.43%
7,374 $1.04 Million
Q3 2020

Nov 13, 2020

SELL
$87.44 - $125.0 $197,614 - $282,500
-2,260 Reduced 39.77%
3,423 $427 Million
Q2 2020

Aug 14, 2020

BUY
$58.39 - $89.31 $331,830 - $507,548
5,683 New
5,683 $508 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.